Literature DB >> 33609600

Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy.

Pyae Phyo1, Xi Zhao1, Allen C Templeton1, Wei Xu1, Jason K Cheung1, Yongchao Su2.   

Abstract

Protein therapeutics carry inherent limitations of membrane impermeability and structural instability, despite their predominant role in the modern pharmaceutical market. Effective formulations are needed to overcome physiological and physicochemical barriers, respectively, for improving bioavailability and stability. Knowledge of membrane affinity, cellular internalization, encapsulation, and release of drug-loaded carrier vehicles uncover the structural basis for designing and optimizing biopharmaceuticals with enhanced delivery efficiency and therapeutic efficacy. Understanding stabilizing and destabilizing interactions between protein drugs and formulation excipients provide fundamental mechanisms for ensuring the stability and quality of biological products. This article reviews the molecular studies of biologics using solution and solid-state NMR spectroscopy on structural attributes pivotal to drug delivery and stability. In-depth investigation of the structure-function relationship of drug delivery systems based on cell-penetrating peptides, lipid nanoparticles and polymeric colloidal, and biophysical and biochemical stability of peptide, protein, monoclonal antibody, and vaccine, as the integrative efforts on drug product design, will be elaborated.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biologics; Biophysical characterization; Drug delivery; Lipid nanoparticles; NMR spectroscopy; Structure-function relationships

Mesh:

Substances:

Year:  2021        PMID: 33609600     DOI: 10.1016/j.addr.2021.02.007

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  6 in total

1.  Structural Fingerprinting of siRNA Therapeutics by Solution NMR Spectroscopy.

Authors:  Owen B Becette; Anh Tran; Jace W Jones; John P Marino; Robert G Brinson
Journal:  Nucleic Acid Ther       Date:  2022-03-09       Impact factor: 4.244

Review 2.  New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy.

Authors:  Krishan Kumar; Varsha Rani; Mohini Mishra; Ruchi Chawla
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-04-28

3.  Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies.

Authors:  Subhabrata Majumder; Deep S Bhattacharya; Alex Langford; Arun Alphonse Ignatius
Journal:  Pharm Res       Date:  2022-02-16       Impact factor: 4.580

4.  The transient expression of recombinant proteins in plant cell packs facilitates stable isotope labelling for NMR spectroscopy.

Authors:  Patrick Opdensteinen; Laura E Sperl; Mariam Mohamadi; Nicole Kündgen-Redding; Franz Hagn; Johannes Felix Buyel
Journal:  Plant Biotechnol J       Date:  2022-07-19       Impact factor: 13.263

Review 5.  Galectins-Potential Therapeutic Targets for Neurodegenerative Disorders.

Authors:  Sapana Chaudhary; Sameer Chaudhary; Sakshi Rawat; Archana Kulkarni; Anwar L Bilgrami; Asma Perveen; Badrah S Alghamdi; Torki Al Zughaibi; Ghulam Md Ashraf; Mohammad Zubair Alam; Tabish Hussain
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

6.  Aggregation Behavior of Structurally Similar Therapeutic Peptides Investigated by 1H NMR and All-Atom Molecular Dynamics Simulations.

Authors:  Johanna Hjalte; Shakhawath Hossain; Andreas Hugerth; Helen Sjögren; Marie Wahlgren; Per Larsson; Dan Lundberg
Journal:  Mol Pharm       Date:  2022-02-01       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.